View Older Stories View More Recent Stories

Oct 29, 2025 09:00AM Erdene to Announce Q3 2025 Results on November 4, 2025
Oct 29, 2025 09:00AM BeyondTrust Experts Reveal Top Cybersecurity Predictions for 2026 and Beyond
Oct 29, 2025 08:45AM Conduent adds GenAI contract analytics to FastCap finance platform
Oct 29, 2025 08:45AM Conduent’s FastCap® Integrates GenAI-Powered Contract and Spend Analytics to Boost Financial Performance
Oct 29, 2025 08:45AM Green Rain Energy Holdings Inc. (OTC:$GREH) Accelerates Expansion with $400K EV Infrastructure Incentive and Launch of Tempe Hilton Project - Showcasing Debt-Free ESCO Model Amid Explosive Sector Grow
Oct 29, 2025 08:36AM AISIX Solutions Inc. Announces Wildfire Risk Intelligence Pilot with Leading Canadian Insurance Brokerage
Oct 29, 2025 08:35AM PostcardMania Selected to Beta Test New Konica Minolta Digital Inkjet Printing Press, One of Only Two in North America
Oct 29, 2025 08:30AM CSX names Kevin Boone CFO, promotes Maryclare Kenney to chief commercial officer
Oct 29, 2025 08:30AM CSX Announces New Leadership Appointments
Oct 29, 2025 08:30AM PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
Oct 29, 2025 08:30AM Northstar Announces Strategic Financing to Advance Surgical Mining of High-Grade Copper at Cam Copper Project
Oct 29, 2025 08:30AM SGTM’s Water Less Garden™ Soil Launches on Amazon – A New Era of Sustainable Gardening Begins
Oct 29, 2025 08:30AM Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics
Oct 29, 2025 08:27AM Blazpay Presale Raises Over $868K While Ethereum and XRP Navigate Market Upswing
Oct 29, 2025 08:11AM AbbVie's upadacitinib meets vitiligo study endpoints
Oct 29, 2025 08:11AM AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
Oct 29, 2025 08:00AM Charles Schwab Provides 1+ Million Meals and Nonprofit Grants During Annual Season of Giving
Oct 29, 2025 08:00AM Signal Advance(R) (OTC:SIGL) Hits Another Cybersecurity Milestone: Validates AI Resistant Analog Encryption
Oct 29, 2025 08:00AM Conduent to Report Third-Quarter 2025 Financial Results on Nov. 7, 2025
Oct 29, 2025 07:35AM Anavex reports long-term cognitive benefits from blarcamesine in alzheimer's trial
Oct 29, 2025 07:30AM Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
Oct 29, 2025 07:30AM Coppernico Metals Expands Concessions at Sombrero
Oct 29, 2025 07:30AM Aclaris Therapeutics to Participate in Three November Healthcare Conferences
Oct 29, 2025 07:20AM Pleasing International Launches RWA Platform “Pleasing Golden,” Introducing Tokenized Gold (PGOLD) and Synthetic Dollar (PUSD)
Oct 29, 2025 07:05AM Extreme Networks Reports First Quarter Fiscal Year 2026 Financial Results
Oct 29, 2025 07:01AM LillyDirect partners with Walmart for Zepbound pickup option
Oct 29, 2025 07:00AM Merck and Eisai discontinue liver cancer trial after survival endpoint missed
Oct 29, 2025 07:00AM UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
Oct 29, 2025 07:00AM Blackstone Mortgage Trust Reports Third-Quarter 2025 Results
Oct 29, 2025 07:00AM Ionis reports third quarter 2025 financial results and highlights progress on key programs
Oct 29, 2025 07:00AM Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
Oct 29, 2025 07:00AM LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
Oct 29, 2025 07:00AM Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
Oct 29, 2025 07:00AM Blackbaud Announces 2025 Third Quarter Results
Oct 29, 2025 06:45AM European Commission approves Merck's KEYTRUDA for head and neck cancer treatment
Oct 29, 2025 06:45AM European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CP
Oct 29, 2025 06:30AM Parsons wins $56 million Diriyah project contract in Saudi Arabia
Oct 29, 2025 06:30AM PIF-Backed Diriyah Company Awards Parsons $56 million (SAR 210 million) Contract for Design and Construction Supervision in Saudi Arabia
Oct 29, 2025 06:05AM Avantor® Reports Third Quarter 2025 Results
Oct 29, 2025 06:00AM Sonoma Biotherapeutics Announces Positive Interim Safety and Efficacy Data from Phase 1 REGULATE-RA Study of SBT-77-7101 in Refractory Rheumatoid Arthritis
Oct 29, 2025 05:10AM Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
Oct 28, 2025 11:30PM Blazpay’s Audited Crypto Presale 2025 Surges Past $925K — Less Than 5 Days Before Next Price Jump
Oct 28, 2025 10:17PM 14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
Oct 28, 2025 05:47PM Anti-Hindu Event at Rutgers Draws Community Outrage, Congressional Concerns and Protest
Oct 28, 2025 05:25PM UT Health San Antonio recognized among nation's top 100 oncology programs
Oct 28, 2025 05:07PM 22nd Century Announces Receipt of $9.5 Million from Settlement of Insurance Claim
Oct 28, 2025 05:05PM Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
Oct 28, 2025 04:48PM SeaFi Launches $ 200,000 IDO for Adix ($ADIX) with Whitelist and Reward Campaigns Active Until November 5th
Oct 28, 2025 04:35PM FIRST RESPONDERS CHILDREN'S FOUNDATION HONORS FIRST RESPONDER HEROES AT SIXTH ANNUAL NATIONAL FIRST RESPONDERS DAY CELEBRATION
Oct 28, 2025 04:30PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
View More Recent Stories View Older Stories